Work

Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19: current evidence and potential mechanisms

Year: 2021

Type: article

Source: Molecular Psychiatry

DOI: 10.1038/s41380-021-01254-3

Authors: Nicolas Hoertel, Marina Sánchez-Rico, Céline Cougoule, Erich Gulbins, Johannes Kornhuber, Alexander Carpinteiro, Katrin Anne Becker, Angela M. Reiersen, Eric J. Lenze, David Seftel, Cédric Lemogne, Frédéric Limosin

Institutions: Inserm, Université Paris Cité, Assistance Publique – Hôpitaux de Paris, Hôpital Corentin-Celton, Institut de Psychiatrie et Neurosciences de Paris, Universidad Complutense de Madrid, Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, University of Duisburg-Essen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsklinikum Erlangen, Essen University Hospital, Washington University in St. Louis, Hôtel-Dieu de Paris

Language: English

Topic: COVID-19 Clinical Research Studies

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3190835544

FWCI: 3.919

Cites: 15

Cited by: 59

Related to: 10